$31.490
+0.009 (+0.03%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CPRX Prediction & Forecast by Similar Chart Analysis
Alphio's CPRX stock price prediction model matches the current Catalyst Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $31.56 (+0.21%). The 1-week path is $32.28 (+2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Catalyst Pharmaceuticals Inc Stock?
CPRX is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is essentially pinned near the announced acquisition price of $31.50 per share, so upside is limited from current levels around $31.44. Since the deal already appears to be the main driver, this is more of a merger-arbitrage situation than a long-term growth investment. Given the lack of a clear premium and the absence of strong proprietary buy signals today, I would not recommend chasing it as a new long-term purchase.
CPRX stock price ended at $31.49 on Tuesday, after rising +0.03%
Catalyst Pharmaceuticals Inc (CPRX) last closed at $31.49, gaining +0.03%. These facts feed the 1-day and 1-week CPRX price prediction above.
Analyst Consensus
Catalyst Pharmaceuticals Inc (CPRX): 4 buy, 0 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Catalyst Pharmaceuticals Inc (CPRX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CPRX, ranked by similarity.
Seasonality analysis for CPRX
Historically the probability of a positive August return for CPRX is 46.51%. December offers the highest probability of a positive month at 100.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CPRX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $21.66 | $28.73 | $29.23 | -8.76% |
| Sep 2026 | $21.99 | $28.56 | $37.23 | -9.29% |
| Oct 2026 | $30.56 | $35.83 | $43.47 | +13.78% |
| Nov 2026 | $35.16 | $35.83 | $41.51 | +13.78% |
| Dec 2026 | $28.80 | $29.88 | $30.18 | -5.10% |
In 2026, Catalyst Pharmaceuticals Inc (CPRX) is projected to range from $21.66 to $43.47.
Catalyst Pharmaceuticals Inc 2026 monthly forecast
In Aug 2026, Catalyst Pharmaceuticals Inc is projected to average $28.73, with a low of $21.66 and high of $29.23.
In Sep 2026, Catalyst Pharmaceuticals Inc is projected to average $28.56, with a low of $21.99 and high of $37.23.
In Oct 2026, Catalyst Pharmaceuticals Inc is projected to average $35.83, with a low of $30.56 and high of $43.47.
In Nov 2026, Catalyst Pharmaceuticals Inc is projected to average $35.83, with a low of $35.16 and high of $41.51.
In Dec 2026, Catalyst Pharmaceuticals Inc is projected to average $29.88, with a low of $28.80 and high of $30.18.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.